Biomarkers | SHC group (n = 14) | WBC group (n = 10) | Mild HIE group (n = 7) | Control group (n = 9) |
---|---|---|---|---|
IL-6 (pg mL−1) | 64.2a (30.4–118.0) | 43.0a (33.1–416.0) | 4.3b (1.2–17.6) | 3.0b (1.3–6.0) |
IL-1β (pg mL−1) | 2.2 (2.0–2.3) | 2.2 (2.1–2.6) | 2.3 (2.1–2.7) | 2.1 (2.0–2.2) |
TNF-α (pg mL−1) | 19.5 (12.5–41.7) | 17.0 (13.3–25.3) | 24.3 (20.2–40.6) | 15.7 (10.8–16.7) |
NSE (μg L−1) | 0.51 (0.38–0.74) | 0.57 (0.38–1.70) | 1.01 (0.40–1.93) | 0.38 (0.32–0.47) |
S100B (ng/ml | 0.08 (0.07–0.15) | 0.10 (0.06–0.15) | 0.12 (0.07–0.21) | 0.08 (0.07–0.12) |
S100 (ng L−1) | 2.9 (0.5–15.5) | 9.5 (0.3–29.8) | 1.6 (0.8–3.6) | 1.5 (0.4–3.8) |
CKBB (ng mL−1) | 1.0 (0.6–1.7) | 0.8 (0.5–1.5) | 0.9 (0.7–1.1) | 1.0 (0.8–1.1) |
L/C ratio | 0.08 (0.04–0.27) | 0.06 (0.04–0.16) | 0.05 (0.03–0.06) | 0.03 (0.02–0.04) |